Endocrine-responsive breast cancer and strategies for combating resistance

被引：693
作者：
Ali, S
Coombes, RC
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Canc Med, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Canc Res Campaign Labs, London W12 0NN, England
来源：
NATURE REVIEWS CANCER | 2002年 / 2卷 / 02期
关键词：
D O I：
10.1038/nrc721
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Deaths from breast cancer have fallen markedly over the past decade due, in part, to the use of endocrine agents that reduce the levels of circulating oestrogens or compete with oestrogen for binding to its receptor. However, many breast tumours either fail to respond or become resistant to endocrine therapies. By understanding the mechanisms that underlie this resistance, we might be able to develop strategies for overcoming or bypassing it.
引用
收藏
页码：101 / +
页数：13
相关论文
共 159 条
  • [1] An ovarian hormone - Preliminary report on its localization, extraction and partial purification, and action in test animals
    Allen, E
    Doisy, EA
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1923, 81 : 819 - 821
  • [2] Estrogen responsiveness and control of normal human breast proliferation
    Anderson, E
    Clarke, RB
    Howell, A
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (01) : 23 - 35
  • [3] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
    Anzick, SL
    Kononen, J
    Walker, RL
    Azorsa, DO
    Tanner, MM
    Guan, XY
    Sauter, G
    Kallioniemi, OP
    Trent, JM
    Meltzer, PS
    [J]. SCIENCE, 1997, 277 (5328) : 965 - 968
  • [4] PHOSPHORYLATION OF THE HUMAN ESTROGEN-RECEPTOR ON TYROSINE-537 IN-VIVO AND BY SRC FAMILY TYROSINE KINASES IN-VITRO
    ARNOLD, SF
    OBOURN, JD
    JAFFE, H
    NOTIDES, AC
    [J]. MOLECULAR ENDOCRINOLOGY, 1995, 9 (01) : 24 - 33
  • [5] The CBP co-activator is a histone acetyltransferase
    Bannister, AJ
    Kouzarides, T
    [J]. NATURE, 1996, 384 (6610) : 641 - 643
  • [6] Bautista S, 1998, CLIN CANCER RES, V4, P2925
  • [7] Beatson GT., 1896, LANCET, V148, P104, DOI DOI 10.1016/S0140-6736(01)72307-0
  • [8] ESTROGEN-DEPENDENT, TAMOXIFEN-RESISTANT TUMORIGENIC GROWTH OF MCF-7 CELLS TRANSFECTED WITH HER2/NEU
    BENZ, CC
    SCOTT, GK
    SARUP, JC
    JOHNSON, RM
    TRIPATHY, D
    CORONADO, E
    SHEPARD, HM
    OSBORNE, CK
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1992, 24 (02) : 85 - 95
  • [9] BOYD S, 1900, BMJ-BRIT MED J, V2, P1161
  • [10] Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
    Bunone, G
    Briand, PA
    Miksicek, RJ
    Picard, D
    [J]. EMBO JOURNAL, 1996, 15 (09) : 2174 - 2183
12345678910